BRCA1 and BRCA2 heterozygous mutant states have been shown to contribute to tumor formation in pancreatic and ovarian cancer mouse models50, 51, consistent with studies that demonstrate that haploinsufficiency for BRCA1 and BRCA2 leads to multiple levels of cellular dysfunction29, 52–54. This evidence concerns the gene BRCA2 and ovarian carcinoma.